Pharma in emerging markets

In emerging markets such as China and India, an increasingly affluent middle class is more able to afford premium health brands. However, difficulties over registration, reimbursement, and the differing mix of influencers in each market can make it difficult to ensure your product gets full access to the marketplace.

Baird’s CMC has done extensive work modeling influencer chains in emerging markets and running research programs to see how best to build demand and maximise penetration into these fast-growing markets.

Baird’s CMC experts: Mark Chataway, Francois Baird, James Snodgrass, Aman Gupta, Hema Viswanathan